S100B and melanoma: Detection of CMCs compared among patients with advanced melanoma and the control group revealed that even though the CellSearch® method turned out to be more prognostic (only in this case a significant relationship with the overall survival was shown), S100-EPISPOT was significantly more sensitive, as the percentage of patients harboring ≥2 CMC was higher.